Evidence check: SHBG in the context of Darmgesundheit

SHBG (sex hormone-binding globulin) is primarily produced in the liver and regulated by insulin, thyroid hormones, and estrogens. Low SHBG is a well-established marker for insulin resistance and metabolic syndrome—conditions linked to gut dysbiosis. Observational studies suggest that a high-fiber diet can increase SHBG, possibly mediated by short-chain fatty acids (SCFAs) from gut microbial fermentation. However, direct causal evidence for a gut health–SHBG axis is limited; most data are mechanistic or cross-sectional. DNA tests for SHBG variants (e.g., rs1799941) have negligible clinical utility for gut health, as single SNP effects are small and confounded by lifestyle. In practice, serum SHBG can serve as a metabolic risk indicator but not as a specific gut health biomarker. Safety note: Low SHBG should be evaluated alongside liver function, insulin resistance, and hormone status, not in isolation.